Skip to main content

Table 1 Acute and late GI/GU toxicity (Maximum score)

From: Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial

Grade GI toxicity scores (n %) GU toxicity scores (n %)
  Acute Late Acute Late
0 23 (48.0%) 45 (95.7%) 10 (21.0%) 38 (80.9%)
1 19 (39.6%)1 2 (4.3%)2 20 (41.7%)3 8 (17.0%)4
2 6 (12.5%) 0 (0%) 17 (35.4%)5 1 (2.1%)
3 0 (0%) 0 (0%) 1 (2.1%) 0 (0%)
4 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Grade 1 or worse 25 (52.1%) 2 (4.3%) 38 (79.2%) 9 (19.1%)
Grade 2 or worse 6 (12.5%) 0 (0%) 18 (37.5%) 1 (2.1%)
  1. 11 subject was Grade 1 at Baseline, 21 subject was Grade 1 at Baseline, 33 subjects were Grade 1 at Baseline, 46 subjects were Grade 1 at Baseline, 53 subjects were Grade 1 at Baseline, 1 subject was Grade 2 at Baseline.